title: Superior vena cava stenting in the 21st century.
abstract: Superior vena cava obstruction (SVCO) is most commonly due to malignant or thrombotic causes. The traditional treatments of surgery, radiotherapy or chemotherapy either have a high morbidity and mortality rate, or a lag period of a few weeks prior to response. Superior vena cava stenting is able to provide rapid relief of symptoms safely in the vast majority of patients. It has now become the first-line treatment for malignant SVCO, and is increasingly being used in benign SVCO. The complication and success rates compare very favourably with the other treatment modalities.
authors: Department of Radiology, John Radcliffe Hospital, Headington, Oxford, UK.
authors: Parveen
authors: P
authors: Warner
authors: Raman
authors: R
authors: Uberoi
mesh_terms: D002404:Catheterization / Q000379:methods*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery*; D013908:Thoracotomy / Q000379:methods*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014654:Vascular Patency